{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:47:31Z","timestamp":1781880451236,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Kunming Health and Technology Talent Training Project, Thousand Engineers Program.","award":["Project Number: 2024-SW (Reserve) \u2013 59"],"award-info":[{"award-number":["Project Number: 2024-SW (Reserve) \u2013 59"]}]},{"name":"Yunnan Provincial Department of Education, Study on the Immune Mechanisms by Which Abnormal Differentiation of CD4+ T Cells Exacerbates the Progression of Pediatric Lupus Nephritis","award":["2025J0305"],"award-info":[{"award-number":["2025J0305"]}]},{"name":"\u201cSpring City Plan\u201d High-Level Talent Training-Spring City Famous Medical Special Project","award":["C202112012"],"award-info":[{"award-number":["C202112012"]}]},{"name":"the Kunming Health Science and Technology Talent Project-10 Projects of China","award":["2023-SW (GUIDE) -07"],"award-info":[{"award-number":["2023-SW (GUIDE) -07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17027-9","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T19:26:07Z","timestamp":1756149967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel COL4A3\u2013COL4A5 variants and digenic inheritance in pediatric Alport syndrome from Southwestern China"],"prefix":"10.1038","volume":"15","author":[{"given":"Ji-Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Mei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Bin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Jing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"issue":"25","key":"17027_CR1","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMra022296","volume":"348","author":"BG Hudson","year":"2003","unstructured":"Hudson, B. G., Tryggvason, K., Sundaramoorthy, M. & Neilson, E. G. Alport\u2019s syndrome, goodpasture\u2019s syndrome, and type IV collagen. N. Engl. J. Med. 348(25), 2543\u20132556 (2003).","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"17027_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/oxfordjournals.ndt.a027821","volume":"13","author":"R Coppo","year":"1998","unstructured":"Coppo, R., Gianoglio, B., Porcellini, M. G. & Maringhini, S. Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National registry of renal biopsies in Children). Group of renal Immunopathology of the Italian Society of Pediatric Nephrology and Group of renal Immunopathology of the Italian Society of Nephrology. Nephrol. Dialysis Transplantation. 13(2), 293\u2013297 (1998).","journal-title":"Nephrol. Dialysis Transplantation"},{"issue":"12","key":"17027_CR3","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1093\/ndt\/gfu254","volume":"29","author":"A Mallett","year":"2014","unstructured":"Mallett, A. et al. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and new Zealand Dialysis and transplant registry cases. Nephrol. Dialysis Transplantation. 29(12), 2277\u20132286 (2014).","journal-title":"Nephrol. Dialysis Transplantation"},{"issue":"5","key":"17027_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0272-6386(89)80165-9","volume":"14","author":"AJ Wing","year":"1989","unstructured":"Wing, A. J. & Brunner, F. P. Twenty-three years of Dialysis and transplantation in europe: experiences of the EDTA registry. Am. J. Kidney Dis. 14(5), 341\u2013346 (1989).","journal-title":"Am. J. Kidney Dis."},{"issue":"10","key":"17027_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/jmedgenet-2013-101713","volume":"50","author":"AA Sch\u00e4ffer","year":"2013","unstructured":"Sch\u00e4ffer, A. A. Digenic inheritance in medical genetics. J. Med. Genet. 50(10), 641\u2013652 (2013).","journal-title":"J. Med. Genet."},{"issue":"9","key":"17027_CR6","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00467-015-3067-9","volume":"30","author":"R Lennon","year":"2015","unstructured":"Lennon, R. et al. Coinheritance of COL4A5 and MYO1E mutations accentuate the severity of kidney disease. Pediatr. Nephrol. 30(9), 1459\u20131465 (2015).","journal-title":"Pediatr. Nephrol."},{"issue":"1","key":"17027_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12882-018-0906-5","volume":"19","author":"K Voskarides","year":"2018","unstructured":"Voskarides, K. et al. COL4A5 and LAMA5 variants co-inherited in Familial hematuria: digenic inheritance or genetic modifier effect? BMC Nephrol. 19(1), 114 (2018).","journal-title":"BMC Nephrol."},{"issue":"7","key":"17027_CR8","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2215\/CJN.19171220","volume":"16","author":"C Quinlan","year":"2021","unstructured":"Quinlan, C. & Rheault, M. N. Genetic basis of type IV collagen disorders of the kidney. Clin. J. Am. Soc. Nephrol. 16(7), 1101\u20131109 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"17027_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00467-016-3452-z","volume":"32","author":"J Stock","year":"2017","unstructured":"Stock, J. et al. Prospective study on the potential of RAAS Blockade to halt renal disease in Alport syndrome patients with heterozygous mutations. Pediatr. Nephrol. 32(1), 131\u2013137 (2017).","journal-title":"Pediatr. Nephrol."},{"issue":"3","key":"17027_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrneph.2012.259","volume":"9","author":"J Kruegel","year":"2013","unstructured":"Kruegel, J., Rubel, D. & Gross, O. Alport syndrome\u2013insights from basic and clinical research. Nat. Rev. Nephrol. 9(3), 170\u2013178 (2013).","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"17027_CR11","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ekir.2017.04.011","volume":"2","author":"T Yamamura","year":"2017","unstructured":"Yamamura, T. et al. Natural history and Genotype-Phenotype correlation in female X-Linked Alport syndrome. Kidney Int. Rep. 2(5), 850\u2013855 (2017).","journal-title":"Kidney Int. Rep."},{"issue":"4","key":"17027_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"JP Jais","year":"2000","unstructured":"Jais, J. P. et al. X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J. Am. Soc. Nephrol. 11(4), 649\u2013657 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"17027_CR13","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00467-014-2797-4","volume":"29","author":"M Oka","year":"2014","unstructured":"Oka, M. et al. Natural history of genetically proven autosomal recessive Alport syndrome. Pediatr. Nephrol. 29(9), 1535\u20131544 (2014).","journal-title":"Pediatr. Nephrol."},{"issue":"12","key":"17027_CR14","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1681\/ASN.2012100985","volume":"24","author":"H Storey","year":"2013","unstructured":"Storey, H., Savige, J., Sivakumar, V., Abbs, S. & Flinter, F. A. COL4A3\/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. J. Am. Soc. Nephrol. 24(12), 1945\u20131954 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"17027_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","volume":"52","author":"MA Mencarelli","year":"2015","unstructured":"Mencarelli, M. A. et al. Evidence of digenic inheritance in Alport syndrome. J. Med. Genet. 52(3), 163\u2013174 (2015).","journal-title":"J. Med. Genet."},{"issue":"1","key":"17027_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/cge.12919","volume":"92","author":"C Fallerini","year":"2017","unstructured":"Fallerini, C. et al. Alport syndrome: impact of digenic inheritance in patients management. Clin. Genet. 92(1), 34\u201344 (2017).","journal-title":"Clin. Genet."},{"issue":"1","key":"17027_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000533915","volume":"15","author":"C Yavas","year":"2024","unstructured":"Yavas, C. et al. A deeper insight into COL4A3, COL4A4, and COL4A5 variants and Genotype-Phenotype correlation of a Turkish cohort with Alport syndrome. Mol. Syndromol. 15(1), 1\u201313 (2024).","journal-title":"Mol. Syndromol."},{"key":"17027_CR18","doi-asserted-by":"crossref","unstructured":"Yava\u015f, C. et al. Whole-Exome Sequencing (WES) results of 50 patients with chronic kidney diseases: a perspective of Alport syndrome. Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira () 68(9), 1282\u20131287 (2002).","DOI":"10.1590\/1806-9282.20220405"},{"issue":"2","key":"17027_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/j.ajkd.2020.03.026","volume":"77","author":"CE Kashtan","year":"2021","unstructured":"Kashtan, C. E. Alport syndrome: achieving early diagnosis and treatment. Am. J. Kidney Dis. 77(2), 272\u2013279 (2021).","journal-title":"Am. J. Kidney Dis."},{"issue":"7","key":"17027_CR20","doi-asserted-by":"publisher","first-page":"e00741","DOI":"10.1002\/mgg3.741","volume":"7","author":"S Shang","year":"2019","unstructured":"Shang, S. et al. Genotype-phenotype correlation and prognostic impact in Chinese patients with Alport syndrome. Mol. Genet. Genom. Med. 7(7), e00741 (2019).","journal-title":"Mol. Genet. Genom. Med."},{"issue":"1","key":"17027_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12882-020-01962-y","volume":"21","author":"L Zhang","year":"2020","unstructured":"Zhang, L., Sun, B. C., Zhao, B. G. & Ma, Q. S. An overview of the multi-pronged approach in the diagnosis of Alport syndrome for 22 children in Northeast China. BMC Nephrol. 21(1), 294 (2020).","journal-title":"BMC Nephrol."},{"issue":"47","key":"17027_CR22","doi-asserted-by":"publisher","first-page":"e27890","DOI":"10.1097\/MD.0000000000027890","volume":"100","author":"JY Chen","year":"2021","unstructured":"Chen, J. Y. et al. A novel compound heterozygous COL4A4 mutation in a Chinese family with Alport syndrome: A care case report. Medicine 100(47), e27890 (2021).","journal-title":"Medicine"},{"issue":"6","key":"17027_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/ndt\/gfae265","volume":"40","author":"R Torra","year":"2025","unstructured":"Torra, R. et al. Diagnosis, management and treatment of the Alport syndrome \u2013\u20092024 guideline on behalf of erknet, ERA and ESPN. Nephrol. Dial Transpl. 40(6), 1091\u20131106 (2025).","journal-title":"Nephrol. Dial Transpl."},{"issue":"3","key":"17027_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1681\/ASN.2012020148","volume":"24","author":"J Savige","year":"2013","unstructured":"Savige, J. et al. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J. Am. Soc. Nephrol. 24(3), 364\u2013375 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"null","key":"17027_CR25","first-page":"1","volume":"117","author":"MC Gregory","year":"1996","unstructured":"Gregory, M. C. et al. Alport syndrome\u2013clinical phenotypes, incidence, and pathology. Contrib. Nephrol. 117(null), 1\u201328 (1996).","journal-title":"Contrib. Nephrol."},{"issue":"5","key":"17027_CR26","first-page":"405","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet. Sci. 17(5), 405\u2013424 (2015).","journal-title":"Genet. Sci."},{"issue":"4","key":"17027_CR27","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","volume":"105","author":"A Levin","year":"2024","unstructured":"Levin, A. et al. Executive summary of the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease: known knowns and known unknowns. Kidney Int. 105(4), 684\u2013701 (2024).","journal-title":"Kidney Int."},{"issue":"24","key":"17027_CR28","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1093\/bioinformatics\/bty536","volume":"34","author":"P Zhang","year":"2018","unstructured":"Zhang, P. et al. PopViz: a webserver for visualizing minor allele frequencies and damage prediction scores of human genetic variations. Bioinformatics 34(24), 4307\u20134309 (2018).","journal-title":"Bioinformatics"},{"issue":"6","key":"17027_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nrg2987","volume":"12","author":"S Augui","year":"2011","unstructured":"Augui, S., Nora, E. P. & Heard, E. Regulation of X-chromosome inactivation by the X-inactivation centre. Nat. Rev. Genet. 12(6), 429\u2013442 (2011).","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"17027_CR30","doi-asserted-by":"publisher","first-page":"null","DOI":"10.1242\/dev.183095","volume":"147","author":"C Patrat","year":"2020","unstructured":"Patrat, C., Ouimette, J. F. & Rougeulle, C. X chromosome inactivation in human development. Development 147(1), null (2020).","journal-title":"Development"},{"issue":"null","key":"17027_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev-genet-120116-024611","volume":"52","author":"R Galupa","year":"2018","unstructured":"Galupa, R. & Heard, E. X-Chromosome inactivation: A crossroads between chromosome architecture and gene regulation. Annu. Rev. Genet. 52(null), 535\u2013566 (2018).","journal-title":"Annu. Rev. Genet."},{"issue":"42","key":"17027_CR32","doi-asserted-by":"publisher","first-page":"40075","DOI":"10.1074\/jbc.M207769200","volume":"277","author":"DB Borza","year":"2002","unstructured":"Borza, D. B. et al. Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains. J. Biol. Chem. 277(42), 40075\u201340083 (2002).","journal-title":"J. Biol. Chem."},{"issue":"30","key":"17027_CR33","doi-asserted-by":"publisher","first-page":"28532","DOI":"10.1074\/jbc.M103690200","volume":"276","author":"DB Borza","year":"2001","unstructured":"Borza, D. B. et al. The NC1 domain of collagen IV encodes a novel network composed of the alpha 1, alpha 2, alpha 5, and alpha 6 chains in smooth muscle basement membranes. J. Biol. Chem. 276(30), 28532\u201328540 (2001).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"17027_CR34","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1172\/JCI118241","volume":"96","author":"B Peissel","year":"1995","unstructured":"Peissel, B. et al. Comparative distribution of the alpha 1(IV), alpha 5(IV), and alpha 6(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients. J. Clin. Invest. 96(4), 1948\u20131957 (1995).","journal-title":"J. Clin. Invest."},{"issue":"6","key":"17027_CR35","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1046\/j.1523-1755.1998.00188.x","volume":"54","author":"SJ Harvey","year":"1998","unstructured":"Harvey, S. J. et al. Role of distinct type IV collagen networks in glomerular development and function. Kidney Int. 54(6), 1857\u20131866 (1998).","journal-title":"Kidney Int."},{"issue":"26","key":"17027_CR36","doi-asserted-by":"publisher","first-page":"20027","DOI":"10.1074\/jbc.M904549199","volume":"275","author":"R Kalluri","year":"2000","unstructured":"Kalluri, R., Cantley, L. G., Kerjaschki, D. & Neilson, E. G. Reactive oxygen species expose cryptic epitopes associated with autoimmune goodpasture syndrome. J. Biol. Chem. 275(26), 20027\u201320032 (2000).","journal-title":"J. Biol. Chem."},{"issue":"5","key":"17027_CR37","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/ki.2013.479","volume":"85","author":"Y Hashimura","year":"2014","unstructured":"Hashimura, Y. et al. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV \u03b15 chain. Kidney Int. 85(5), 1208\u20131213 (2014).","journal-title":"Kidney Int."},{"issue":"8","key":"17027_CR38","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1681\/ASN.2018030228","volume":"29","author":"T Horinouchi","year":"2018","unstructured":"Horinouchi, T. et al. Detection of splicing abnormalities and Genotype-Phenotype correlation in X-linked Alport syndrome. J. Am. Soc. Nephrol. 29(8), 2244\u20132254 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"17027_CR39","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1681\/ASN.2013080912","volume":"25","author":"V Morini\u00e8re","year":"2014","unstructured":"Morini\u00e8re, V. et al. Improving mutation screening in Familial hematuric nephropathies through next generation sequencing. J. Am. Soc. Nephrol. 25(12), 2740\u20132751 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"17027_CR40","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/ckj\/sfaa170","volume":"13","author":"R Torra","year":"2020","unstructured":"Torra, R., Furlano, M. & Ars, E. How genomics reclassifies diseases: the case of Alport syndrome. Clin. Kidney J. 13(6), 933\u2013935 (2020).","journal-title":"Clin. Kidney J."},{"issue":"8","key":"17027_CR41","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2215\/CJN.01000116","volume":"11","author":"N Kamiyoshi","year":"2016","unstructured":"Kamiyoshi, N. et al. Genetic, clinical, and pathologic backgrounds of patients with autosomal dominant Alport syndrome. Clin. J. Am. Soc. Nephrol. 11(8), 1441\u20131449 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"17027_CR42","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/ndt\/gfh099","volume":"19","author":"X Pan","year":"2004","unstructured":"Pan, X. et al. Detection of COL4A5 gene mutations in Chinese patients with alport\u2019s syndrome. Nephrol. Dialysis Transplantation. 19(5), 1123\u20131128 (2004).","journal-title":"Nephrol. Dialysis Transplantation"},{"issue":"null","key":"17027_CR43","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.mce.2018.06.005","volume":"477","author":"TS Assmann","year":"2018","unstructured":"Assmann, T. S., Recamonde-Mendoza, M., de Souza, B. M., Bauer, A. C. & Crispim, D. MicroRNAs and diabetic kidney disease: systematic review and bioinformatic analysis. Mol. Cell. Endocrinol. 477(null), 90\u2013102 (2018).","journal-title":"Mol. Cell. Endocrinol."},{"issue":"10","key":"17027_CR44","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/humu.9453","volume":"27","author":"K King","year":"2006","unstructured":"King, K., Flinter, F. A. & Green, P. M. A two-tier approach to mutation detection in the COL4A5 gene for Alport syndrome. Hum. Mutat. 27(10), 1061 (2006).","journal-title":"Hum. Mutat."},{"issue":"2","key":"17027_CR45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/(SICI)1098-1004(1999)13:2<124::AID-HUMU4>3.0.CO;2-Z","volume":"13","author":"KE Plant","year":"1999","unstructured":"Plant, K. E., Green, P. M., Vetrie, D. & Flinter, F. A. Detection of mutations in COL4A5 in patients with Alport syndrome. Hum. Mutat. 13(2), 124\u2013132 (1999).","journal-title":"Hum. Mutat."},{"issue":"5","key":"17027_CR46","doi-asserted-by":"publisher","first-page":"e0177685","DOI":"10.1371\/journal.pone.0177685","volume":"12","author":"JH Liu","year":"2017","unstructured":"Liu, J. H. et al. Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport syndrome. PloS One. 12(5), e0177685 (2017).","journal-title":"PloS One"},{"issue":"3","key":"17027_CR47","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ekir.2022.12.007","volume":"8","author":"A Doreille","year":"2023","unstructured":"Doreille, A. et al. Exome-First strategy in adult patients with CKD: A cohort study. Kidney Int. Rep. 8(3), 596\u2013605 (2023).","journal-title":"Kidney Int. Rep."},{"key":"17027_CR48","doi-asserted-by":"crossref","unstructured":"Gao, M. et al. Diagnostic application of exome sequencing in Chinese children with suspected inherited kidney diseases. Front. Genet. 13, 933636 (2022).","DOI":"10.3389\/fgene.2022.933636"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17027-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:27:21Z","timestamp":1757435241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17027-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17027"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17027-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee at the Kunming Children\u2019s Hospital, Yunnan, China (2022-03-02-K01). Written informed consent was obtained from the legal guardians or parents for publication of case details and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"31313"}}